Related Topics News -

     
 Detail   |   Print 
     
先聲藥業SIM0709於德國獲批臨床試驗
2026-11-09T  
先聲藥業澤普昔替尼治療類風濕關節炎新藥上市申請獲受理
2026-11-06T  
先聲藥業周二回購52.8萬股 涉536萬元
2026-11-04T  
先聲藥業取得澤普昔替尼皮科適應症獨家商業化授權
2026-11-02T  
《大行》瑞銀降聯邦制藥評級至「中性」 重申先聲藥業為首選
2026-10-22T  
先聲藥業昨回購142.8萬股 涉資逾1,534萬元
2026-10-14T  
先聲藥業周五回購159.8萬股 涉1,737萬元
2026-10-09T  
先聲藥業RSV預防單抗「英沐樂」獲國家藥監局批准上市
2026-09-04T  
先聲藥業與羅氏就SIM0660訂立獨家授權許可協議 有權收取7,500萬美元首付款
2026-09-01T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.